File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Real world efficacy and tolerability of direct-acting antiviral for treatment of chronic hepatitis C infection: interim results of a territory-wide study in Hong Kong

TitleReal world efficacy and tolerability of direct-acting antiviral for treatment of chronic hepatitis C infection: interim results of a territory-wide study in Hong Kong
Authors
Issue Date2018
PublisherSpringer New York LLC. The Journal's web site is located at http://www.springer.com/west/home/medicine?SGWID=4-10054-70-173733513-0
Citation
27th Annual Conference of the Asian Pacific Association for The Study of the Liver (APASL 2018), New Delhi, India, 14-18 March 2018. In Hepatology International, 2018, v. 12 n. Suppl. 2, p. S519-S520, abstract no. HCV-90 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/264591
ISSN
2017 Impact Factor: 4.117
2015 SCImago Journal Rankings: 0.669

 

DC FieldValueLanguage
dc.contributor.authorHui, YT-
dc.contributor.authorWong, G-
dc.contributor.authorLiu, SHK-
dc.contributor.authorLiu, K-
dc.contributor.authorCheung, S-
dc.contributor.authorMa, YK-
dc.contributor.authorBut, D-
dc.contributor.authorMak, WY-
dc.contributor.authorTsang, O-
dc.contributor.authorLai, KB-
dc.contributor.authorLoo, CK-
dc.contributor.authorNg, A-
dc.contributor.authorLai, MS-
dc.contributor.authorChan, CW-
dc.contributor.authorLau, JYL-
dc.contributor.authorFan, T-
dc.contributor.authorHui, AJ-
dc.contributor.authorLam, CY-
dc.contributor.authorCheung, WI-
dc.contributor.authorChan, J-
dc.contributor.authorLam, K-
dc.contributor.authorLai, LSW-
dc.contributor.authorLuk, WF-
dc.contributor.authorLi, MKK-
dc.contributor.authorLao, WC-
dc.contributor.authorLam, JTW-
dc.contributor.authorTsang, S-
dc.contributor.authorKung, KN-
dc.contributor.authorTong, RKN-
dc.contributor.authorChan, YK-
dc.contributor.authorChow, WH-
dc.contributor.authorCheung, CS-
dc.contributor.authorTo, CT-
dc.contributor.authorLi, CW-
dc.contributor.authorWong, J-
dc.contributor.authorTao, WL-
dc.contributor.authorChan, WS-
dc.contributor.authorChan, R-
dc.contributor.authorLee, K-
dc.contributor.authorYau, W-
dc.contributor.authorChan, A-
dc.contributor.authorHo, YH-
dc.contributor.authorKan, YM-
dc.contributor.authorLui, KL-
dc.contributor.authorShan, E-
dc.contributor.authorFung, JYY-
dc.contributor.authorChan, HLY-
dc.contributor.authorYuen, RMF-
dc.contributor.authorWong, VWS-
dc.date.accessioned2018-10-22T07:57:29Z-
dc.date.available2018-10-22T07:57:29Z-
dc.date.issued2018-
dc.identifier.citation27th Annual Conference of the Asian Pacific Association for The Study of the Liver (APASL 2018), New Delhi, India, 14-18 March 2018. In Hepatology International, 2018, v. 12 n. Suppl. 2, p. S519-S520, abstract no. HCV-90-
dc.identifier.issn1936-0533-
dc.identifier.urihttp://hdl.handle.net/10722/264591-
dc.languageeng-
dc.publisherSpringer New York LLC. The Journal's web site is located at http://www.springer.com/west/home/medicine?SGWID=4-10054-70-173733513-0-
dc.relation.ispartofHepatology International-
dc.relation.ispartof27th Annual Conference of the Asian Pacific Association for The Study of the Liver (APASL 2018)-
dc.titleReal world efficacy and tolerability of direct-acting antiviral for treatment of chronic hepatitis C infection: interim results of a territory-wide study in Hong Kong-
dc.typeConference_Paper-
dc.identifier.emailLiu, SHK: drkliu@hku.hk-
dc.identifier.emailBut, D: drdbut@hku.hk-
dc.identifier.emailFung, JYY: jfung@hkucc.hku.hk-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityFung, JYY=rp00518-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.hkuros293852-
dc.identifier.volume12-
dc.identifier.issueSuppl. 2-
dc.identifier.spageS519-
dc.identifier.epageS520-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats